May 15 is going to be the tipping point for me in all likelihood...
Brad on the Feb 2013 conference call:
"As you also are probably aware, in late 2012 we completed an 850:1 reverse stock split. The reverse split was a necessary step for us to seek a listing on a stock exchange. We expect we will have such a listing this summer after we post our 2013 first quarter results. There are several benefits to being listed on a stock exchange, but the most important is the ability to seek institutional investment in our shares. The institutions that were looking at investing in our Company over the past few years declined for the most part, citing our lack of a stock exchange listing. Going forward, these investors will have the ability to participate in our Company once we are listed on an exchange."
Brad on the 2014 conference call:
"It is not a matter of if, but when" in reference to an uplisting.
Ive been holding for 14 months now, and I have been increasing my position seemingly quarterly (averaging down if you can call it that in this instance) .... I consider myself a shareholder with a long term mindset (not a trader with a quick $ in mind)
I want, no I NEED MusclePharm to come through for me on the May 15th CC... Profits + uplist + SEC conclusion = Avocet's greengasm & me adding even more to my position.
The absence of atleast 1 of the above 3 catalysts on the May 15th conference call will = liquidation for me.
At some point, calling myself a long-term shareholder and using that as a crutch to justify continuing to buy and hold this stock will have to fall by the wayside.
AI
Market Data 
Markets 
